Suppliers / Akshat Pharma

Akshat Pharma

India Updated 9 July 2026

Akshat Pharma is an API manufacturer based in India. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Glycopyrronium US FDA 1

Also appears on these molecule pages

Glycopyrronium API

Questions about Akshat Pharma

Does Akshat Pharma hold a US DMF or a CEP?
Akshat Pharma holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Akshat Pharma make?
1 molecule is on record against Akshat Pharma, including Glycopyrronium. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Akshat Pharma?

Ask Fred what the record holds on Akshat Pharma, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Cipla shares 1 molecule Olon shares 1 molecule Cohance Lifesciences shares 1 molecule Shilpa Pharma Lifesciences shares 1 molecule Harman Finochem shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability